- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05204732
Acoustic and Perceptual Effects of Intonation Training in Gender Diverse People (B6702021001262)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background and Problem Statement. Speech training in gender diverse individuals focuses on aspects of communication that strongly influence gender perception. Findings from the literature suggest that a listener's gender perception is determined not only by pitch, but also by other components such as intonation. However, the nature and extent of pitch changes required to alter gender perception are not known. In speech therapy, intonation training is frequently used for speech feminization. However, empirical evidence for this is lacking.
Research questions and/or hypotheses Thisresearch investigates the short- and long-term effects of intonation training on acoustic voice characteristics, gender perception and findings of gender-diverse individuals using a randomized sham-controlled trial (RCT). Based on findings from the literature, (a) gender-congruent values are expected for intonation parameters, in addition (b) assessments of gender that fit the gender identity of the person and (c) an improvement in self-assessment after intonation training in the short and long term. This study will lead to new insights into the relationship between intonation and gender perception and makes an important contribution to the evidence for the use of intonation training.
Research Protocol An RCT will be used. Gender diverse individuals will be recruited through the Ghent University Hospital. Inclusion criteria are: diagnosis of gender dysphoria established by the multidisciplinary gender team, age between 18 and 60 years, normal hearing and Dutch mother tongue. Taking into account the expertise of the research group and the low-threshold recruitment through the gender clinic of UZ Gent, a total of n=20 participants is a very feasible number. Subjects will be randomly assigned to the experimental (intonation training) or control group (receiving a placebo intervention). Randomization will be stratified by age group and baseline speaking fundamental frequency. The experimental group will receive 4 weeks (1h/week) of intonation training with a pre- and post-voice assessment and a follow-up assessment after 8 weeks. The control group will receive sham therapy at a similar duration and frequency, also with a pre- and post-measurement and a follow-up assessment after 8 weeks. The control group will receive 4 more weeks (1 hour/week) of intonation training with a post measurement (due to ethical reasons). The multidimensional speech assessments will be blinded and completed and well-defined training programs will be used. The primary outcome measures are: acoustic intonation parameters, gender perception by listeners and self-assessment and client satisfaction. Linear mixed models with post-hoc pairwise comparisons will be used to analyze the evolution of continuous data within and between groups. ICC models and Cohen's kappa will be used to analyze inter- and intra rater reliability.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
East Flanders
-
Ghent, East Flanders, Belgium, 9000
- Ghent University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Normal hearing (using ISO standard audiometry)
- Native Dutch speaker
Exclusion Criteria:
- A history of neurological disorders
- Previous phonosurgery or speech therapy
- Vocal pathology (using videolaryngostroboscopy)
- Smokers.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental group
|
The participants will receive intonation training (1h/week) for four weeks, aiming for more gender congruent intonation patterns.
|
|
Sham Comparator: Control group
|
The participants will first receive four weeks of sham therapy (with no expected effect on speech), during which information on voice functioning, voice surgery, voice hygiene, and transgender health care will be provided.
In addition, during sham therapy, active intervention will be given around nonverbal communication.
After four weeks of sham therapy, for ethical reasons, subjects in this group will also receive four weeks of intonation training (aiming for more gender congruent intonation patterns).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in general intonation shift (Hz and ERB)
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
|
The general intonation shift is the mean size of the general increase or decrease of the fundamental frequency during the utterance.
For the calculation of this parameter, the first and last vowel of the sentence were selected and the fo of the vowels were determined.
Subsequently, the general intonation shift was calculated as the difference between start and end fo.
Based on the size of this difference, the general intonation shift was categorized as an upward, downward or flat intonation shift.
A difference smaller than 1.570884399 ERB was considered as a flat intonation shift.
Finally, the percentage of upward, downward and flat intonation shifts could be determined.
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
|
|
Change in final intonation shift (Hz and ERB)
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
|
The Final intonation shift indicates the average size of the upward or downward intonation shift at the end of the utterance.
This parameter was calculated as the difference between the fo at the beginning of the final rise or drop and the fo at the end.
The beginning was located on the last stressed vowel and the end of the final rise or drop was located on the last unstressed vowel.
In case that the utterance ended with a stressed vowel, the intonation shift was derived from the difference in fo within this vowel.
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
|
|
Change in general pitch range (Hz and ERB)
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
|
This parameter was calculated as the difference between the minimum (5th percentile) and the maximum fo (95th percentile) of the utterance.
For this calculation the "Intonantion and stress trajectory" script was used (Corthals, 2019a; Van Borsel, Vandaele, & Corthals, 2013).
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
|
|
Change in pitch variation index (Hz/s and ERB/s)
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
|
This parameter was determined by the sum of the absolute value of all pitch changes during the utterance between percentile 5 and 95 divided by the total duration of the utterance.
The pitch variation index reflects the size and speed of the intonation maneuvers.
For this parameter the script "Intonation and stress trajectory" was used (Corthals, 2019a; Van Borsel, Vandaele, & Corthals, 2013).
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 20 min.)
|
|
Gender perception of the voice
Time Frame: During a listening experiment (+/- 40 minutes).
|
A listening experiment with femininity ratings using a visual analogue scale (VAS: very feminine - neutral - very masculine).
|
During a listening experiment (+/- 40 minutes).
|
|
Change in patient's satisfaction with their voice - VAS
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
Visual analoge scales investigating the client's satisfaction of the therapy and psychosocial functioning: examples:
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
|
Change in patient's satisfaction with their voice - TWVQ
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
Trans Women Voice Questionnaire: 30 questions investigating trans women's experiences with their voice (1 = never or seldom; 2 = sometimes; 3 = often; 4 = usual or always).
The score can range from 30 to 120.
A lower score indicates higher satisfaction with the voice.
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
|
Change in patient's satisfaction with their voice - VHI
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
Voice Handicap Index: 30 questions investigating the impact of voice on the quality of life (0 = never; 1 = almost never; 2 = sometimes; 3 = almost always; 4 = always) .
The score can range from 30 to 120.
A lower score indicates higher satisfaction with the voice.
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in speech fundamental frequency (SFF)
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
median speech fundamental frequency (SFF)
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
|
Change in formant frequency 1 (F1)
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
F1 of the vowels /a/, /i/ and /u/
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
|
Change in formant frequency 2 (F2)
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
F2 of the vowels /a/, /i/ and /u/
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
|
Change in formant frequency 3 (F3)
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
F3 of the vowels /a/, /i/ and /u/
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
|
Change in formant frequency 4 (F4)
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
F4 of the vowels /a/, /i/ and /u/
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
|
Change in formant frequency 5 (F5)
Time Frame: baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
F5 of the vowels /a/, /i/ and /u/
|
baseline (before treatment) - at the end of the treatment period (after 4 weeks) - 4 (and 8) weeks after the end of the treatment period (after 8 (and 12) weeks (each measurement +/- 5 min.)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Evelien D'haeseleer, University Ghent
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BC-11303
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gender Dysphoria
-
University Hospitals Cleveland Medical CenterKerecis Ltd.RecruitingGender Dysphoria, AdultUnited States
-
Region SkaneRecruiting
-
University of ChicagoNot yet recruitingGender Dysphoria, Adult | VaginoplastyUnited States
-
Rigshospitalet, DenmarkRecruitingGender Identity | Gender Incongruence | Gender Dysphoria, AdultDenmark
-
Amsterdam UMC, location VUmcRecruitingGender Dysphoria, AdolescentNetherlands
-
University Hospital, ToulouseCompletedGender Dysphoria, AdolescentFrance
-
Dartmouth-Hitchcock Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsEnrolling by invitationGender Dysphoria | Transgender Persons | Transsexualism | Transgenderism | Gender Incongruence | Phalloplasty | Gender Dysphoria, AdultUnited States
-
Centre Hospitalier Henri LaboritRecruitingGender Dysphoria, AdultFrance
-
University of Colorado, DenverCompletedGender Dysphoria, AdolescentUnited States
-
Hospices Civils de LyonCompletedGender Dysphoria Vaginoplasty SexualityFrance
Clinical Trials on Intonation training
-
Instituto de Investigación Hospital Universitario...CompletedPost Stroke Aphasia
-
The Hong Kong Polytechnic UniversitySuspended
-
Fujian University of Traditional Chinese MedicineNot yet recruiting
-
Bnai Zion Medical CenterUnknown
-
Beth Israel Deaconess Medical CenterNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedStroke | Cerebral Infarction | Aphasia | Cerebrovascular Accident | ApoplexyUnited States
-
University of MiamiRecruiting
-
Nevada State UniversityCompleted
-
Northeastern UniversityOregon Health and Science University; University of California, RiversideRecruiting
-
University of Trás-os-Montes and Alto DouroCompletedLipid Metabolism Disorders | Sarcopenia | Osteoporosis | Overweight and Obesity | Personal Satisfaction | Hypertension With Complications and Secondary HypertensionPortugal